Tharimmune, Inc. (THAR)
2.98
+0.06
(+2.05%)
USD |
NASDAQ |
Jan 20, 12:33
Tharimmune EPS Diluted (Quarterly): -0.3367 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | -0.4374 |
| ETHZilla Corp. | -16.80 |
| Flora Growth Corp. | -9.048 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.102M |
| Total Expenses (Quarterly) | 2.102M |
| Enterprise Value | 94.92M |
| Earnings Yield | -131.0% |
| Normalized Earnings Yield | -131.04 |